Syndax Pharmaceuticals Inc. (SNDX) Declined -15.36% or -1.12 To Price $6.17 On Monday


Syndax Pharmaceuticals Inc. (SNDX) declined -15.36% or -1.12 to $6.17. It is around 406043 shares traded, which is 107.05% compare to the average total volume 379305. The market cap of SNDX is $144.10 million. The year to date change is -32.24%. The 52 week price range is from $5.7 to $15.2. Price of SNDX have changed 10.45% during last week. It have changed 7.68% over last month, -2.41% over last 3 months, -30.11% over last 6 months and -36.94% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SNDX is 7.21. It is 16.86% above current price. The 200-day Moving Averages for SNDX is 9.04. It is 46.52% above current price. The 52-week High is 15.2. It is 146.35% from the current price. The 52-week Low is 5.7. It is -7.62% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of SNDX is 4.87 on 2018-09-28. Short % to float is 7.94%. There are some statistics of SNDX. It is has market cap $144.10 million. The share outstanding is 23.36 million. The average volume is 379305. The revenue is 305000. The percent of top 15 Institution holding is 73.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SNDX is -79.02%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SNDX is -59.22%.


Tags:

Share this post